Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuromyelitis Optica Spectrum Disorder”

170 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 170 results

Testing effectiveness (Phase 2)Ended earlyNCT01339455
What this trial is testing

Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica

Who this might be right for
Neuromyelitis Optica
University of Calgary 3
Not applicableStudy completedNCT04629274
What this trial is testing

In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMO

Who this might be right for
Neuromyelitis Optica
Imcyse SA 15
Not applicableStudy completedNCT03942952
What this trial is testing

PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingNeuromyelitis OpticaAcute Disseminated Encephalomyelitis+1 more
University of Texas Southwestern Medical Center 49
Large-scale testing (Phase 3)Study completedNCT02073279
What this trial is testing

Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica (NMO)NMO Spectrum Disorder (NMOSD)
Hoffmann-La Roche 95
Very early researchWithdrawnNCT06548620
What this trial is testing

RD06-04 in Patients With Active Autoimmune Diseases

Who this might be right for
SLESclerosisANCA Associated Vasculitis+5 more
Nanjing Bioheng Biotech Co., Ltd.
Not applicableStudy completedNCT04687332
What this trial is testing

IA or PE - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune Diseases

Who this might be right for
Neurological Autoimmune Diseases
University Medical Center Mainz 32
Not applicableLooking for participantsNCT05966467
What this trial is testing

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

Who this might be right for
Neuromyelitis Optica Spectrum DisorderNMOSDAQP4+ NMOSD
Alexion Pharmaceuticals, Inc. 122
Not applicableLooking for participantsNCT05566769
What this trial is testing

Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

Who this might be right for
Neuromyelitis Optica
Ad scientiam 103
Not applicableLooking for participantsNCT07202494
What this trial is testing

Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum DisordersMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)+7 more
Assistance Publique Hopitaux De Marseille 700
Early research (Phase 1)Looking for participantsNCT06680037
What this trial is testing

Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

Who this might be right for
B-cell Mediated Autoimmune Disorders
TG Therapeutics, Inc. 32
Not applicableNot Yet RecruitingNCT07182409
What this trial is testing

Efficacy and Safety of Monoclonal Antibody in Acute Phase of Neuromyelitis Optica Spectrum Disorder

Who this might be right for
NMOSD
First Affiliated Hospital of Chongqing Medical University 40
Large-scale testing (Phase 3)WithdrawnNCT03829566
What this trial is testing

Autologous Transplant To End NMO Spectrum Disorder

Who this might be right for
Neuromyelitis OpticaDevic's DiseaseNMO Spectrum Disorder
Northwestern University
Not applicableLooking for participantsNCT06280755
What this trial is testing

Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.

Who this might be right for
Multiple SclerosisNMO Spectrum DisorderMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+2 more
icometrix 7,000
Testing effectiveness (Phase 2)Study completedNCT04614454
What this trial is testing

High Frequency Impulse Therapy for Neuropathic Pain in NMOSD

Who this might be right for
Neuromyelitis Optica
Massachusetts General Hospital 46
Not applicableActive Not RecruitingNCT00445367
What this trial is testing

Biobank For MS And Other Demyelinating Diseases

Who this might be right for
Multiple SclerosisTransverse MyelitisNeuromyelitis Optica+2 more
Accelerated Cure Project for Multiple Sclerosis 3,226
Not applicableLooking for participantsNCT06443333
What this trial is testing

National, Multicentric Registry Study on Neuroimmunological Diseases in China

Who this might be right for
Multiple SclerosisNMO Spectrum DisorderMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+3 more
Xuanwu Hospital, Beijing 7,000
Testing effectiveness (Phase 2)WithdrawnNCT05974293
What this trial is testing

A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders

Who this might be right for
NMO Spectrum DisorderSpasticity, Muscle
Michael, Levy M.D.,Ph.D.
Testing effectiveness (Phase 2)Looking for participantsNCT06453694
What this trial is testing

Efgartigimod for the Treatment of Acute Optic Neuritis

Who this might be right for
Optic Neuritis
Anastasia Vishnevetsky, MD, MPH 20
Not applicableUnknownNCT05414487
What this trial is testing

Effects of Ofatumumab Treatment on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating Diseases

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum DisorderDemyelinating Diseases of the Central Nervous System
Tianjin Medical University General Hospital 34
Early research (Phase 1)Study completedNCT01759602
What this trial is testing

C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation

Who this might be right for
Neuromyelitis Optica
Michael Levy 10
Load More Results